Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$80,123
-$20,960 QoQ
Shares Held
11,317
+11.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#104
of 164 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. GRFS ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in GRFS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,123 | 11,317 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $101,083 | 10,149 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $94,521 | 10,456 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $70,118 | 10,497 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,407,094 | 121,721 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,245,406 | 136,259 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,593,620 | 173,976 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,085,003 | 147,219 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $2,381,682 | 280,198 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,446,183 | 234,770 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,704,327 | 227,637 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,957,766 | 338,850 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,089,056 | 275,072 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,855,230 | 195,430 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,765,469 | 217,030 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,584,544 | 207,319 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,515,419 | 190,641 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $32,544,069 | 1,875,739 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $55,685,533 | 3,052,935 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $62,895,527 | 3,122,916 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||